Fecal immunochemical test definition

Fecal immunochemical test or “FIT” means the primary screening method for the IGS program to test for hemoglobin in the feces, a possible sign of colorectal cancer.
Sample 1Sample 2Sample 3

Examples of Fecal immunochemical test in a sentence

  • Colorectal Cancer Screening – Fecal immunochemical test for blood (FIT), Cologuard (FIT-fecal) DNA testing, Computed Tomographic (CT) colonography, flexible sigmoidoscopy, or routine colonoscopy provided in accordance with the most recently published recommendations established by the American College of Gastroenterology, in Consultation with the American Cancer Society, for the ages, family histories and frequencies referenced in such recommendations.

  • Fecal immunochemical test accuracy in average-risk colorectal cancer screening.

  • Fecal immunochemical test accuracy in familial risk colorectal cancer screening.

  • Fecal immunochemical test (FIT) for routine screening for colorectal cancer is considerednot medically necessary and not covered when criterion III.

  • You pay a $0 copay for certain Medicare-covered lab services including Hemoglobin A1c, Urine Protein, Prothrombin (Protime), Urine Albumin, Fecal immunochemical test (FIT), and COVID-19 testing.

  • Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study.

  • Fecal immunochemical test (FIT) is considered medically necessary and covered for routine screening for colorectal cancer when both the following (A.

  • Fecal immunochemical test detects sessile serrated adenomas and polyps with a low level of sensitivity.

  • Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study.

  • Fecal immunochemical test pro- gram over 4 rounds of annual screening: a retrospective study.

Related to Fecal immunochemical test

  • Clean coal technology demonstration project means a project using funds appropriated under the heading “Department of Energy—Clean Coal Technology,” up to a total amount of $2,500,000,000 for commercial demonstration of clean coal technology, or similar projects funded through appropriations for the Environmental Protection Agency. The federal contribution for a qualifying project shall be at least 20 percent of the total cost of the demonstration project.

  • Fluoroscopic imaging assembly means a subsystem in which X-ray photons produce a visual image. It includes the image receptor(s) such as the image intensifier and spot-film device, electrical interlocks, if any, and structural material providing linkage between the image receptor and diagnostic source assembly.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Cardiopulmonary resuscitation or "CPR" means artificial ventilation or external

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Step therapy protocol means a protocol or program that establishes the specific